Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilengitide in Asymptomatic Metastatic Androgen Independent Prostate Cancer
NCT00103337Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Jan 2005
- Primary completion
- Oct 2007
- Modality
- Small Molecules, Modified Peptides
- Countries
- 1
01
Overview
A Phase 2 trial of cilengitide in prostate cancer (PCa), sponsored by National Cancer Institute. Started Jan 2005; status: completed.
02
Drugs
cilengitide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00103337.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00103337.